Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hyperthermia and ICI in advanced gastrointestinal malignancies with liver metastases
NCT07118566Phase 2Not yet recruiting
- Sponsor
- China Medical University
- Start
- Aug 2025
- Primary completion
- May 2029
01
Overview
Phase 2, open-label trial in gastric cancer (GC) and colorectal cancer (CRC) (2 cohorts), sponsored by China Medical University. Primary endpoint: Objective Response Rate at 12 months. Planned start Aug 2025; status: not yet recruiting.
02
Conditions
gastric cancer (GC)colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT07118566.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07118566.